Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 154 for “"Systemic Therapy"”.
-
Metabolomic Biomarkers of Response to Systemic Therapy in Colorectal Cancer
… America. Besides surgery and radiation, chemotherapy administration is one of the mainstay treatment options used to improve CRC prognosis, and ultimately patient outcomes. Chemotherapies are selected empirically by oncologists, and only a fraction of these patients will experience the benefit …
-
Palliative Systemic Therapy for Salivary Gland Cancer From Common to Rare
Radboud University, 18 november 2022
-
Ultrasound-based functionalized biopsy markers for lesion tracking through neoadjuvant systemic therapy
Submission original under an indefinite embargo labeled 'Open Access'. The submission was exported from vireo on 2025-10-19 without embargo terms
-
A comparison of two cases in experiential systemic therapy : a case study approach
… contributed to a successful case of Experiential Systemic Couples Therapy as compared to a non-successful case using a qualitative, exploratory case study. The main purposes were: (a) to generate concepts that may have led to or hindered therapeutic change, (b) to investigate the process of change …
-
Role of Systemic Therapy for Advanced/Metastatic Gastric Carcinoma in the First-line Setting
… for advanced/metastatic gastric cancer (A/MGC). Systemic therapy is often the preferred treatment for A/MGC since it offers survival benefits. Exploration of immunotherapies and/or targeted agents in A/MGC offer more treatment combinations than standard systemic chemotherapies. Nivolumab, an …
-
The effect of exercise alone and in combination with systemic therapy on breast cancer
… blood flow, which may translate to improved chemotherapy delivery to otherwise hypo-perfused tumour regions. Whether exercise acts an adjunct to our current systemic therapies in improving breast cancer outcomes is a question that remains unanswered. The overall hypothesis of this thesis is that …
-
Xenobiotic transporter expression in breast cancer patients treated with neoadjuvant systemic therapy: implications for therapy
… in modulating breast cancer response to chemotherapy. These are Pgp (P-glycoprotein), MRP1 (multidrug resistance-associated protein 1), and BCRP (breast cancer resistance protein). My first aim was to investigate expression of these proteins before and after neoadjuvant chemotherapy (NAC) for …
-
Proliferative activity, measured by MIB-1, and outcome in primary breast cancer following systemic therapy
There is increasing interest in the use of systemic therapy before surgery for large but operable breast cancers. It has the theoretical advantage of giving priority to the eradication of micrometastatic disease. Studies of primary systemic therapy (PST) show that tumour regression rates are high …
-
Measuring treatment adherence of Experiential Systemic Therapy and Supported Feedback Therapy in the Alcohol Recovery Project
… of treatment adherence of Experiential Systemic Therapy (ExST) and Supported Feedback Therapy (SFT) in the Alcohol Recovery Project. First, is the Adherence Rating Scale Reliable and Valid? Second, to what extent do the therapists adhere to and emulate the respective treatments described …
-
Bone healing in diabetic and osteoporotic conditions: Effects of systemic therapy and material optimizations on healing.
Radboud University, 16 maart 2023
-
EARLY PREDICTION OF NEOADJUVANT SYSTEMIC THERAPY RESPONSE IN TRIPLE NEGATIVE BREAST CANCER USING FUNCTIONAL MAGNETIC RESONANCE IMAGING
Neoadjuvant systemic therapy (NAST) is administered prior to surgery to reduce tumor burden in patients with triple-negative breast cancer (TNBC); however, about half of TNBC patients do not respond to NAST and develop a distant spread within five years. Early assessment of NAST response for …
-
An ecological assessment of the efficacy of individual and couples treatment formats of Experiential Systemic Therapy for alcohol dependency
… differential treatment efficacy of Experiential Systemic Therapy (ExST) with a comparison treatment called Supported Feedback Therapy (SFT) as it is applied to the problem of alcohol dependency. The inquiry also compares the treatment effectiveness of ExST when offered to the individual alcoholic …
-
Treatment response using CT-based rigidity analysis in an animal model of lytic musculoskeletal lesions subjected to systemic therapy
Cancer is a global epidemic; over 1.5 million new cancer diagnoses and greater than 600,000 deaths due to cancer are estimated to occur in the United States within the year 2015 alone. Approximately two-thirds of patients with bone metastases will experience pain, pathological fractures, spinal …
-
Utilization of systemic therapy in cancer patients near the end-of-life in the pre- vs. post- checkpoint inhibitor eras
Introduction: Use of systemic therapy for advanced cancer patients near the end-of-life (EOL) is a low-value medical practice. However, immune checkpoint inhibitor (ICI) use at the EOL may be on the rise due to a favorable toxicity profile. We hypothesize that systemic therapy use in the last 30 …
-
Course of clinical response during primary systemic therapy with a dose-dense 4 cycles regime of adriamycin and docetaxel in patients with operable cancer of the breast
Background: <br>In contrast to adjuvant chemotherapy (AST), primary systemic therapy (PST) allows the observation of clinical response under treatment, serving as an in-vivo chemosensitivity test. One possibility to assess tumor response is the consideration and analysis of clinical parameters such …
-
The Effect of Collaborative Reviews of Electronic Patient-Reported Outcomes on the Congruence of Patient- and Clinician-Reported Toxicity in Cancer Patients Receiving Systemic Therapy: Prospective, Multicenter, Observational Clinical Trial
… symptom monitoring. Methods Patients receiving systemic therapy in a (neo-)adjuvant or noncurative intention setting captured ePRO for 52 symptoms over an observational period of 90 days. At 3-week intervals, randomly selected symptoms were reviewed between the patient and physician for …
-
Real World Treatment Patterns and Outcomes Among Patients with Early Non-Small Cell Lung Cancer
… treating advanced metastatic NSCLC with targeted systemic therapies. As early and comprehensive care can potentially improve and extend the lives of patients, attention is now turning towards Stages I – IIIA, or early NSCLC (eNSCLC), with new and recent approval of neoadjuvant and adjuvant …
-
Clinical outcomes in patients with pemphigus vulgaris receiving a combination rituximab and intravenous immunoglobin therapy protocol
… the skin and mucous membranes. The conventional therapy for this disease is high dose corticosteroids and immunosuppressive agents, which have a marked side effect profile. Therefore, subjects who suffer from this disease are not only affected by the sequelae of the pathology of pemphigus, but …
-
The In Vitro Development of a Metabolomic Test for Response to Antineoplastic Drugs
… would be useful. We postulate that a response to systemic therapy is associated with characteristic changes in extracellular metabolites. Methods: Multiple tumor cell lines were exposed to a variety of chemotherapeutics. Supernatants collected at baseline and at 72 hours were analyzed by gas …
-
Prognose von extrapulmonalen neuroendokrinen G3-Karzinomen des Urogenitaltrakts
… of metastases. Endpoints including response to systemic therapy, progression-free survival (PFS), and overall survival (OS), were analyzed using Kaplan-Meier estimates. Results: Of 51 evaluable patients, 22 had the primary tumor in the prostate and 29 in the urinary bladder; 26% of the cohort …
Page 1 of 8